LDL-C (mmol/L)

2.27 (1.93, 3.06)

2.39 (2.07, 3.24)

−1.35

0.49

SUA (mmol/L)

305.96 (262.71, 385.35)

296.19 (247.74, 349.26)

−1.41

0.16

LPa (mmol/L)

214.6 (101.59, 389.06)

210.41 (133.78, 330.77)

−0.26

0.80

HbA1c (%)

6.15 (5.6, 6.8)

6.1 (5.7, 6.9)

−0.63

0.53

药物使用(%)

ACEI/ARB(例)

34 (25%)

16 (15.5%)

3.18

0.08

ACEI+利尿剂(例)

38 (27.9%)

32 (31.1%)

0.28

0.60

抗血小板药物

110 (80.9%)

76 (73.8%)

1.71

0.19

他汀类药物(例)

115 (84.6%)

89 (86.4%)

0.16

0.69

二甲双胍(例)

28 (20.6%)

25 (24.3%)

0.46

0.49

SGLT-2i (例)

1 (0.8%)

2 (1.9%)

0.59

0.44

DPP-4i (例)

7 (5.3%)

3 (2.9%)

0.91

0.34

阿卡波糖(例)

15 (11%)

14 (3.6%)

0.36

0.55

HRV时域指标

SDNN (ms)

113.71 ± 30.67

118,59 ± 32.25

−1.19

0.24

SDANN (ms)

105.43 ± 30.72

112.03 ± 35.01

−1.55

0.12

SDNN index (ms)

42.64 ± 12.95

45.02 ± 11.84

−1.46

0.15

RMSSD (ms)

29.99 ± 10.58

31.75 ± 10.08

−1.46

0.15

PNN50 (%)

6 (3, 10.75)

7 (4, 12)

−1.68

0.09

HRV频域指标

HF (ms)

124.4 (73.35, 190.48)

138.5 (89.3, 198.9)

−1.21

0.23

LF (ms)

191.75 (110.1, 294.93)

221.7 (126.4, 311)

−1.79

0.07

LF/HF

1.46 (1.12, 1.94)

1.59 (1.05, 2.06)

−0.92

0.36